Nakazato, Yuji (2002) Tachycardiomyopathy. [Journal (Paginated)]

Full text available as:

[img] HTML


Sustained chronic tachyarrhythmias often cause a deterioration of cardiac function known as tachycardia-induced cardiomyopathy or tachycardiomyopathy.1 It has been recognized that the tachycardiomyopathy occurs in experimental models2 and also in patients with supraventricular or ventricular tachycarrhythmias.3,4,5,6 Generally, cardiac function will recover if drug or catheter ablation therapy is successfully performed. Phillips and Levine7 initially presented this concept in 1949 for the relationship between rapid atrial fibrillation and reversible left ventricular (LV) failure. However, it might be difficult to define its cause and effect relationship when cardiomyopathy and tachycardia are identified simultaneously. The reversibility of LV dysfunction may often be variable and the precise mechanisms of the pathophysiological features of this phenomenon should be elucidated. Although excellent and comprehensive review articles by Fenelon G, et al.8 and Shinbane JS et al 9 regarding these topics have already been published, I will firstly present a typical case and then review the basic and clinical characteristics of tachycardiomyopathy in this article.

Item Type:Journal (Paginated)
Subjects:JOURNALS > Indian Pacing and Electrophysiology Journal
ID Code:4298
Deposited By: Indian Pacing and Electrophysiology, Journal
Deposited On:02 May 2005
Last Modified:11 Mar 2011 08:56

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Packer DL, Bardy GH, Worley SJ, et al. Tachycardia-induced cardiomyopathy: a reversible form of LV dysfunction. AM J Cardiol 1986;57:563-570.

2. Coleman HN, Taylor RR, Pool PE, et al. Congestive heart failure following chronic tachycardia. Am Heart J 1971;81:790-798.

3. Lemery R, Brugada P, Cheriex E, et al. Reversibility of atachycardia-induced LV dysfunction after closed chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol 1987;60:1406-1408.

4. Cruz F, Cheriex E, Smeets, et al. Reversibility of tachycardia induced cardiomyopathy after cure of incessant supraventicular tachycardia. J Am Coll Cardiol 1990;16:739-744.

5. Fyfe D, GilleteP, Crawford F, et al. Resolution of dilated cardiomyopathy after surgical ablation of ventricular tachycardia in a child. J Am Coll Cardiol. 1987;9:231-234.

6. Rakovec P, Lajovic J, Dolenc M. Reversible congestive cardiomyopathy due to chronic ventricular tachycardia. PACE, 1989;12:542-545.

7. Phillips E, Levine S. Auricular fibrillation without other evidence of heart disease: a cause of reversible heart failure. Am J Med 1949;7:478-489.

8. Fenelon G, Wijns W, Andries E, et al. Tachycardiomyopathy:mechanisms and clinical implications. PACE 1996;19:95-106.

9. Shinbane JS, Wood MA, Jensen N, et al. Tachycardia-induced cardiomyopathy:a review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-715.

10. Nakazato Y, Nakata Y. Successful treatment of ectopic atrial tachycardia-induced cardiomyopathy with pilsicainide. Heart 2001;86, 642.

11. Gallagher JJ. Tachycardia and cardiomyopathy:the chicken-egg dilemma revisited. J Am Coll Cardiol 1985;6:1172-1173.

12. Brugada P and Andries E. Tachycardiomyopathy. The most frequently unrecognized cause of heart failure ? Acta Cardiologica 1993;2:165-169.

13. Tomita M, Spinale FG, Crawford FA, et al. Changes in LV volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Circulation 1991;83:635-644.

14. Wolff M, de Tombe P, Harasawa Y, et al. Alterations in LV mechanics, energetics and contractile reserve in experimental heart failure. Circ Res 1992; 70:516-529.

15. Burchell S,Spinale F, Crawford F, et al. Effects of chronic tachycardia induced cardiomyopathy on the beta adrenergic receptor system. J Thorac Cardiovasc Surg 1992; 104:1006-1012.

16. Francis GS. Hemodynamic and neurohumoral response to dynamic exercise: normal subjects versus patients with heart disease. Circulation 1987;76(suppl VI):11-17.

17. Berg MP, Veldhuisen DJ, Crijns HJGM, et al. Reversion of tachycardiomyopathy after beta-blocker. Lancet 1993;341:1667.

18. Waagstein F, Hjalmarson A, Varnauskas E, et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy Br Heart J, 1975;37:1022-1036.

19. Gilbert EM, Anderson JL, Deitchman D, et al. Long-term ßblocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med 1990;88:223-229.

20. Moe GW, Stopps TP, Angus C, et al. Alteration in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol 1989;13:173-179.

21. Spinale F, Pearce A, Schulte B, et al. Ventricular function and Na+, K+, ATPase activity and distribution with chronic supraventricular tachycardia. Cardiovasc Res 1991; 25:138-144.

22. Spinale F, Clayton C, Tanaka R, et al. Myocardial Na+, K+-ATPase in tachycardia induced cardiomyopathy. J Moll Cell Cardiol 1992; 24:277-294.

23. Spinale F, Fulbright M, Mukherjee R, et al. Relation between ventricular and myocyte function with tachycardia induced cardiomyopathy. Circ Res 1992; 71:174-187.

24. He JQ, Conklin MW, Foell JD, et al. Reduction in density of transverse tubules and L-type Ca2+ channels in canine tachycardia-induced heart failure. Cardiovasc Res 2001;49:298-307.

25. Williams RE, Kass DA, Kawagoe Y, et al. Endomyocardial gene expression during development of pacing tachycardia- induced heart failure in the dog. Circ Res 1994;75:615-623.

26. Shite J, Qin F, Mao W, et al. Antioxidant vitamins attenuate oxidative stress cardiac dysfunction in tachycardia- induced cardiomyopathy. J Am Coll Cardiol 2001;38:1734-40.

27. Spinale FG, Tanaka R, Crawford FA, et al. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 1992;85:717-729.

28. Clemo HF, Stambler BS, Baumgarten CM. Persisitent activation of a swelling-activated cation current in ventricular myocytes from dogs with tachycardia-induced congestive heart failure. Circ Res 1998;83:147-157.

29. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 1999;42:270-283.

30. Nabauer M, Kaab S. Potassium channel down-regulation in heart failure. Cardiovasc Res 1998;37:324-334.

31. Armoundas AA, Wu R, Juang G, et al. Electrical and structural remodeling of the failing ventricle. Pharmacology & Therapeutics 2001;92:213-230.

32. Tomaselli GF, Beuckelmann DJ, Calkins HG, et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation 1994;90:2534-2539.

33. Tsuji Y, Opthof T, Kamiya K, et al. Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle. Cardiovasc Res 2000;48;300-309.

34.. Han W, Chartier D, Li D, et al. Ionic remodeling of cardiac purkinje cells by congestive heart failure. Circulation 2001;104:2095-2100

35.Gillet PC, Garson A Jr. Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia. Circulation 1977;56:571-575.

36. Lemery R, Brugada P, Della Bella P, et al. Non-ischemic ventricular tachycardia: Clinical course and long term follow-up in patients without clinically overt heart disease. Circulation 1989;79: 990-999.

37. Paelinck B, Vermeersch P, Stockman D, et al. Usefulness of low-dose dobutamine stress echocardiography in predicting recovery of poor LV function in atrial fibrillation dilated cardiomyopathy. Am J Cardiol 1999;83:1668-1671.)

38. Timek TA, Dagum P, Lai DT et al. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy. Circulation 2001 ;104[suppl I]:I-47-I-53.

39. Hayano M, Kawasaki T, Eguchi Y, et al. A case of tachycardia-induced cardiomyopathy due to chronic ectopic atrial tachycardia. Clin Cardiol 1993;16:831-841.

40.. Mtalka MS, Deedwania PC. Atrial fibrillation in patients with heart failure : pharmacological options. Congest Heart Fail 2001:7:22-29.

41.. Chen R.P-C., Ignaszewski AP, Robertson MA, et al. Successful treatment of supraventricular tachycardia-induced cardiomyopathy with amiodaraone:case report and review of literature. Can J Cardiol 1995;11:918-922.

42. Sternick EB, Bahia FC, Gontijo Filho B, et al. Arq Bras Cardiol 1992;58:209-214.

43. Anguera I, brugada J, Roba M, et al. Outcomes after radiofrequency catheter ablation of atrial tachycardia. Am J Cardiol 2001;87:886-890.

44. Giovanni JV, Dindar A, Griffith MJ, et al. Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children. Heart 1998 ;79 :588-592.

45. Sanchez C, Benito F, Moreno F. Reversibility of tachycardia-induced cardiomyopathy after radiofrequency ablation of incessant supraventricular tachycardia in infants. Br Heart J 1995;74:332-333.

46. Aguinaga L, Primo J, Anguera I, et al. Long-term follow-up in patients with the permanent form of junctional reciprocating tachycardia treated with radiofrequency ablation. PACE 1998 ;21(part I) :2073-2078.

47. Noë P, Driel VV, Wittkampf F,et al. Rapid recovery of cardiac function after catheter ablation of persistent junctional reciprocating tachycardia in children. PACE 2002;25:191-194.

48. Rodriguez L, Smeets J, Xie B, et al. Improvement in LV function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993; 72:1137-1141.

49. Chugh SS, Shen WK, Luria DM, et al. First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure. J Cardiovasc Electrophysiol 2002;11:328-329.

50. Jaggarao N, Nanda AS, Daubert JP. Ventricular tachycardia induced cardiomyopathy:improvement with radiofrequency ablation. PACE 1996;19(part I):2073-3078.

51. Kim YH, Goldberger J, Kadish A. Treatment of ventricular tachycardia-induced cardiomyopathy by transcatheter radiofrequency ablation. Heart 1996 ;76 :550-552.

52. Singh B, Kaul U, Talwar KK, et al. Reversibility of "tachycardia induced cardiomyopathy" following the cure of idiopathic left ventricular tachycardia using radiofrequency energy. PACE 1996 ;19 :1391-1392.

53. Grimm W, Menz V, Hoffmann J, et al. Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia. PACE 2001 ;24 :166-171.

54. Ott P, Kelly PA, Mann DE, et al. Tachycardia-induced cardiomyopathy in a cardiac transplant recipient :treatment with radiofrequency ablation. J Cardiovasc Electrophysiol, 1995;6:391-395.

55. Giorgi LV, Hartzler GO, Hamaker WR. Incessant focal atrial tachycardia: a surgically remediable cause of cardiomyopathy. J Thoracic Cardiovas Surg 1984 ;87 :466-469.

56. Rabbani L, Wang P, Couper G, et al. Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia. Am Heart J 1991; 121:816-819.


Repository Staff Only: item control page